810143C

14:0 NBD PE

Avanti Polar Lipids 810143C

• Sinónimos: 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
• Fórmula empírica (notación de Hill): C₃₉H₇₀N₅O₁₁P
• Número de CAS: 474942-82-0
• Peso molecular: 815.97
• UNSPSC Code: 12352211
• NACRES: NA.25

Propiedades

• assay: >99% (TLC)
• form: liquid
• packaging: pkg of 1 × 1 mL (810143C-1mg); pkg of 5 × 1 mL (810143C-5mg)
• manufacturer/tradename: Avanti Polar Lipids 810143C
• concentration: 1 mg/mL (810143C-1mg); 1 mg/mL (810143C-5mg)
• shipped in: dry ice
• storage temp.: −20°C

Descripción

Application

14:0 NBD PE is suitable for the preparation of phospholipid vesicles for lipid mixing assay. It is also suitable to use as fluorescent phospholipid derivative to study the effect of its exchange between β-lactoglobulin (β-LG) and phosphatidylcholine (POPC) bilayers.

Biochem/physiol Actions

NBD PE (1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)) can be used liposome preparation. In which, it might serve as a measure of steady-state fluorescence anisotropy. This might be useful to analyse the mitochondrial membrane structure.

Packaging

5 mL Amber Glass Screw Cap Vial (810143C-1mg)

5 mL Amber Glass Screw Cap Vial (810143C-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• pictograms: GHS06,GHS08
• signalword: Danger
• hcodes: H302 - H315 - H319 - H331 - H336 - H351 - H361d - H372 - H412
• pcodes: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• target_organs: Central nervous system
• Storage Class: 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• wgk_germany: WGK 3
• flash_point_f: does not flash
• flash_point_c: does not flash